(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GENETRAQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GENETRAQ

ST13

US500000090230678

Class

35

Filing

90230678

Registration

6720488

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

05/03/2022

Trademark type

Word

Nice classes

35

Filing date

10/01/2020

Registration date

05/03/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/03/2022

Last transaction

05/03/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

03/17/2022

First use in commerce

03/17/2022

Drawing code

4

Owner type

16

Owner location

Reading, PA, US

Examiner

AYALA, LOURDES

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SAI-MedPartners, LLC

Representatives

Elliott J Stein STEVENS & LEE, P.C.

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Providing an online database in the field of business development of gene therapy products featuring product development timelinesmanagement and compilation of computerized databases in the field of clinical trials for business purposes and commercialization status and partnerships

Publications

History of USPTO decisions and trademark events.

24 publications found

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

05/03/2022

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/31/2022

ALIE

ASSIGNED TO LIE

03/24/2022

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

03/22/2022

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

03/20/2022

IUAA

USE AMENDMENT ACCEPTED

03/20/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/18/2022

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

03/18/2022

IUAF

USE AMENDMENT FILED

03/18/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/17/2022

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/17/2022

EAAU

TEAS AMENDMENT OF USE RECEIVED

03/17/2022

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

09/18/2021

GNFR

FINAL REFUSAL E-MAILED

09/18/2021

CNFR

FINAL REFUSAL WRITTEN

09/18/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/17/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/16/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/16/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/16/2021

GNRT

NON-FINAL ACTION E-MAILED

02/16/2021

CNRT

NON-FINAL ACTION WRITTEN

02/16/2021

DOCK

ASSIGNED TO EXAMINER

02/04/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/17/2020

NWAP

NEW APPLICATION ENTERED

10/05/2020

Continuous trademark protection

Get notified about every new filing that threatens GENETRAQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.